Intelligence in 20 presymptomatic subjects with an increased risk (>95%) for carrying the gene for Huntington's disease (HD) was studied in a prospective, casecontrol, single blind study. No significant differences between the groups were detected for intelligence indices and subtest scores (Wechsler Adult Intelligence Scale). The high level of the performance IQ and the significant discrepancy between performance IQ and verbal IQ found in both the high risk and the low risk groups contrasted with our expectations based on anamnestic information, general clinical opinion, and the results of previously conducted studies. We propose that psychosocial circumstances could explain the test results and discuss the consequences of our findings for clinical genetics practice.
Abstract
Intelligence in 20 presymptomatic subjects with an increased risk (>95%) for carrying the gene for Huntington's disease (HD) was studied in a prospective, casecontrol, single blind study. No significant differences between the groups were detected for intelligence indices and subtest scores (Wechsler Adult Intelligence Scale). The high level of the performance IQ and the significant discrepancy between performance IQ and verbal IQ found in both the high risk and the low risk groups contrasted with our expectations based on anamnestic information, general clinical opinion, and the results of previously conducted studies. We propose that psychosocial circumstances could explain the test results and discuss the consequences of our findings for clinical genetics practice. ( DNA testing has also found its way to departments of neurology and will be increasingly used for confirmation of the (differential) diagnosis in patients suspected of having the disease. Before the advent of DNA testing programmes, the diagnosis was based on involuntary, choreic movements and a positive family history. The eventual clinical diagnosis of HD is obviously psychologically devastating to the partner and his/her offspring, who have seen the patient's parent, sib, or another close relative become progressively disabled. The diagnosis was often made in the later stages of the disease, when personality or cognitive changes or both were already prominent. Before the diagnosis was made, families were often left in the dark and adequate support could not be offered because of lack of recognition of symptoms or knowledge of the disease. Moreover, misdiagnosis of HD as depression, for example, sometimes occurs in the early stages of the disease, which has led to unsuccessful psychotherapy. Therefore, an early diagnosis of the disease could be relevant for appropriate support and for preparing a patient and his family more adequately for the future deterioration.
The actual sequence of appearance of the three major symptoms (movement disorders, personality changes, and cognitive changes) is not known. Manifest choreic movements may be preceded by early affective or In this article we address the question whether subjects at high risk (HD+) can be distinguished from those at low risk (HD-) with regard to intelligence indices. Given the characteristics and the insidious course of the disease, our hypothesis was that the HD+ group would perform significantly less well than the HD-group in the Wechsler Adult Intelligence Scale, especially in the performance tasks. Performance tasks are considered more sensitive than verbal tasks to disturbances of the integrity of the central nervous system.
Participants and methods

TESTING PROCEDURE
The presymptomatic test for HD, using DNA linkage analysis, has been available at the Clinical Genetics Centre in Leiden since October 1987.'4 No official announcement was made by the Genetics Centre as a restrained policy was applied. Information about the availability of the test was given by either the general practitioner, neurologist, clinical genetics service, relatives, or patient organisation. The counselling protocol included at least two sessions of pretest counselling, and was undertaken along the lines of a structured protocol following the international guidelines. The testing protocol has been previously described.'4 Inclusion criteria for the testing programme included: age 18 years or older, absence of major mental illness or the intention to commit suicide after an unfavourable result, and the ability to give informed consent. Neurological and neuropsychological examinations were not performed as a standard part of the testing protocol. If applicants had reason to believe that they were perhaps affected, they were referred to the neurologist of the team (RACR). If the genetic counsellor or psychologist suspected an applicant to be affected, it was thoroughly discussed whether the applicant was preoccupied with early signs of the disease and whether he/she wished to learn about confirmation of the disease when identified as a carrier of the HD gene. When applicants denied early symptoms or avoided discussing them, this was considered and appreciated as warding off behaviour. Test results were disclosed about three months after the intake session.
PARTICIPANTS
Between 1 April 1989 and 31 March 1991, 114 subjects at 50% risk entered the presymptomatic testing programme at the Clinical Genetics Centre, Leiden. Seventy-three could be given results and participated in a psychological follow up study. Twenty-nine persons with an increased risk (96-98%) and 44 persons with a decreased risk (2-4%) were diagnosed by linkage analysis. All were tested at their own request and gave informed consent to participate in the testing procedure and fol- As the pattern of the intelligence indices is similar for the HD+ group as well as for the HD-group, we can reject a HD linked genetic explanation and consider a psychosocial hypothesis to explain the findings. The social environment of our subjects may have discouraged academic training. Presumably growing up in family affected with HD, under threat of this serious disease, has led to educational underachievement and perhaps a lack of ambition. Social and educational variables are known to have an important influence on intelligence indices, especially on VIQ. However, the discrepancy between the intelligence indices could be a chance finding as it has not been found in other studies. The psychosocial hypothesis needs to be confirmed by further study with a control group from a normal population, matched for socioeconomic background.
Giordani et a" also proposed psychosocial variables of influence on the test results of HD+ and HD-subjects. They found no differences between carriers and non-carriers and both groups performed less well than normal controls. However, their normal controls are likely to come from an intellectual community of students which is, in view of the psychosocial hypothesis, a mismatched control group. In fact, any study addressing cognition of HD patients by a comparison with either normal controls or other patient groups fails to take the burdened history of HD patients into account. As predictive DNA testing becomes available for more neurodegenerative disorders, psychosocial group characteristics can be studied at a baseline level. This is an essential methodological improvement to current research designs in which premorbid data are generally lacking. Deviations from norms and from control data, which were previously interpreted as sequelae of brain pathology, might prove to result from influences indirectly related to specific diseases. The 
